Mvabea (Johnson & Johnson) Market Research Report 2026: Epidemiology, Pipeline Analysis, Insights & Forecasts, 2020-2025, 2025-2030F, 2035F
Dublin, March 10, 2026 (GLOBE NEWSWIRE) -- The "Mvabea Market Report 2026: Epidemiology, Pipeline Analysis, Market Insights & Forecasts" has been added to ResearchAndMarkets.com's offering.
The Mvabea market has seen significant growth, driven by recurrent Ebola outbreaks in endemic regions, global emergency response initiatives, early adoption of MVA-based vaccine platforms, and involvement of international health organizations. Humanitarian vaccination campaigns have further propelled this market.
Looking ahead, the focus on pandemic preparedness, increased funding for emerging infectious disease vaccines, expansion of stockpiling strategies, and the use of vector-based vaccine technologies are expected to drive market growth. Other trends include the deployment of Ebola vaccination programs, the expansion of two-dose vaccine regimens, and enhanced international collaboration for disease control.
The increasing incidence of Ebola is a major driver for the Mvabea market. The disease, transmitted through human-wildlife interactions and exacerbated by urbanization and weakened healthcare systems, remains a significant public health threat. The Monoclonal Vaccine Against Ebola (MVABE) offers targeted immunity through antibodies that neutralize the Ebola virus, significantly reducing infection or disease severity. This was evidenced in April 2025, when the WHO reported Uganda had ended a Sudan virus outbreak, demonstrating the effectiveness of MVABE in outbreak control.
A noteworthy trend in the vaccine market is the regulatory approval of Imvanex (MVA-BN) for adolescents aged 12 to 17. In September 2024, Bavarian Nordic received FDA and EMA approvals for this mpox vaccine, marketed under various names including JYNNEOS. This live virus vaccine is adept for immunocompromised individuals and demonstrates high efficacy in mpox and smallpox prevention. The strategic distribution of this vaccine enhances the market's growth potential.
Significant industry activity includes the acquisition of Bavarian Nordic A/S by Innosera ApS in July 2025. The acquisition will facilitate increased investment in vaccine manufacturing and expand global supply capabilities, fostering long-term growth and innovation in the vaccine sector.
Major players like Johnson & Johnson dominate the mvabea market, with North America being the largest region in 2025, while Asia-Pacific is predicted to be the fastest-growing region. The report encompasses regions including Asia-Pacific, Europe, North America, South America, the Middle East, and Africa, with countries like Australia, India, China, South Korea, Japan, UK, France, Germany, USA, and Canada detailed in the analysis.
Tariffs present challenges by increasing costs of imported materials and logistics, impacting government vaccination programs. However, this has inspired regional manufacturing partnerships and localized facilities, which could enhance vaccine accessibility in the long term.
The Mvabea market research report offers detailed insights into the industry, including market size, regional shares, and emerging trends. Key product types include Mvabea (MVA-BN-Filo) and Zabdeno (Ad26.ZEBOV), designed for Ebola virus disease prevention and outbreak control. This report is crucial for stakeholders seeking to understand the current landscape and future opportunities in the mvabea market.
In conclusion, the Mvabea market, characterized by its focus on a two-dose vaccine regimen against the Zaire Ebola virus, is set for robust growth bolstered by strategic acquisitions, regulatory approvals, and increasing global health investments. The market consists of sales of Ebola vaccine regimens, with values based on 'factory gate' prices, reflecting the goods and related services sold by manufacturers directly to end customers or intermediaries.
Report Highlights
Report Scope
For more information about this report visit https://www.researchandmarkets.com/r/pssjtj
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.